Familial Isolated Pituitary Adenoma
What's New
Last Posted: Feb 28, 2023
- Differentiated thyroid carcinoma in sporadic and familial presentations of acromegaly: A case series.
Rogozinski Amelia, et al. Annales d'endocrinologie 2020 0 (5) 482-486 - The role of AIP variants in pituitary adenomas and concomitant thyroid carcinomas in the Netherlands: a nationwide pathology registry (PALGA) study.
Coopmans E C, et al. Endocrine 2020 0 (3) 640-649 - Three Novel MEN1 Variants in AIP-Negative Familial Isolated Pituitary Adenoma Patients.
Yarman Sema, et al. Pathobiology : journal of immunopathology, molecular and cellular biology 2019 1 1-7 - Do the aryl hydrocarbon receptor interacting protein variants (Q228K and Q307R) play a role in patients with familial and sporadic hormone-secreting pituitary adenomas?
Yarman Sema, et al. Genetic testing and molecular biomarkers 2015 7 (7) 394-8 - Aryl hydrocarbon receptor interacting protein (AIP) mutations occur rarely in sporadic parathyroid adenomas.
Pardi Elena, et al. The Journal of clinical endocrinology and metabolism 2013 7 (7) 2800-10 - Familial isolated pituitary adenoma
From NCATS Genetic and Rare Diseases Information Center - Prevalence of AIP mutations in a large series of sporadic Italian acromegalic patients and evaluation of CDKN1B status in acromegalic patients with multiple endocrine neoplasia.
Occhi G, et al. European journal of endocrinology / European Federation of Endocrine Societies 2010 9 (3) 369-76 - Assessment of p27 (cyclin-dependent kinase inhibitor 1B) and aryl hydrocarbon receptor-interacting protein (AIP) genes in multiple endocrine neoplasia (MEN1) syndrome patients without any detectable MEN1 gene mutations.
Igreja Susana, et al. Clinical endocrinology 2009 2 (2) 259-64 - Mutations in the aryl hydrocarbon receptor interacting protein gene are not highly prevalent among subjects with sporadic pituitary adenomas.
Barlier Anne, et al. The Journal of clinical endocrinology and metabolism 2007 5 (5) 1952-5
About Rare Diseases PHGKB
Rare Disease PHGKB is an online, continuously updated, searchable database of published scientific literature, CDC and NIH resources, and other information that address the public health impact and translation of genomic and other precision health discoveries into improved health outcomes related to rare diseases...more
Content Summary
Selected Rare Diseases
- Alpha-1 Antitrypsin Deficiency
- Amyotrophic Lateral Sclerosis
- Brugada Syndrome
- Cerebral Palsy
- Cystic Fibrosis
- Duchenne Muscular Dystrophy
- Eclampsia
- Erythema Multiforme
- Familial Mediterranean Fever
- Fragile X Syndrome
- Gaucher Disease
- Glomerulonephritis
- Graves Disease
- Hemophilia
- Huntington Disease
- Microcephaly
- Myasthenia Gravis
- Phenylketonuria
- Retinitis Pigmentosa
- Severe Combined Immunodeficiency
Disclaimer: Articles listed in the Public Health Knowledge Base are selected by Public Health Genomics Branch to provide current awareness of the literature and news. Inclusion in the update does not necessarily represent the views of the Centers for Disease Control and Prevention nor does it imply endorsement of the article's methods or findings. CDC and DHHS assume no responsibility for the factual accuracy of the items presented. The selection, omission, or content of items does not imply any endorsement or other position taken by CDC or DHHS. Opinion, findings and conclusions expressed by the original authors of items included in the update, or persons quoted therein, are strictly their own and are in no way meant to represent the opinion or views of CDC or DHHS. References to publications, news sources, and non-CDC Websites are provided solely for informational purposes and do not imply endorsement by CDC or DHHS.
- Page last reviewed:Feb 1, 2024
- Content source: